Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ovid Therapeutics Inc. | General Counsel, Secretary | Common Stock | 28.1K | $60.5K | $2.15 | Feb 22, 2024 | Direct |
Ovid Therapeutics Inc. | General Counsel, Secretary | Stock Option (Right to Buy) | 169K | Feb 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OVID | Ovid Therapeutics Inc. | Feb 22, 2024 | 2 | $0 | 4 | Feb 26, 2024 | General Counsel, Secretary |
OVID | Ovid Therapeutics Inc. | Feb 23, 2023 | 1 | $0 | 4 | Feb 27, 2023 | General Counsel, Secretary |
OVID | Ovid Therapeutics Inc. | Apr 8, 2022 | 2 | $0 | 4 | Apr 12, 2022 | General Counsel, Secretary |
OVID | Ovid Therapeutics Inc. | Feb 3, 2022 | 1 | $0 | 4 | Feb 4, 2022 | General Counsel, Secretary |